Aspiriant, LLC Pfizer Inc Transaction History

Aspiriant, LLC

$2.75 Billion
Q4 2024

A detailed history of Aspiriant, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Aspiriant, LLC holds 31,539 shares of PFE stock, worth $805,190. This represents 0.03% of its overall portfolio holdings.

Number of Shares

31,539

Previous 38,012 17.03%

Holding current value

$805,190

Previous $1.1 Million 24.0%

% of portfolio

0.03%

Previous 0.04%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 16, 2025	SELL	$24.8 - $30.19 $160,530 - $195,419	-6,473 Reduced 17.03%	31,539 $836,000
Q3 2024 Oct 17, 2024	BUY	$27.7 - $31.39 $62,989 - $71,380	2,274 Added 6.36%	38,012 $1.1 Million
Q2 2024 Jul 15, 2024	SELL	$25.26 - $29.6 $129,255 - $151,463	-5,117 Reduced 12.52%	35,738 $999,000
Q1 2024 Apr 15, 2024	SELL	$25.89 - $29.73 $67,857 - $77,922	-2,621 Reduced 6.03%	40,855 $1.13 Million
Q4 2023 Jan 26, 2024	SELL	$26.13 - $33.94 $8,439 - $10,962	-323 Reduced 0.74%	43,476 $1.25 Million
Q3 2023 Oct 17, 2023	BUY	$32.09 - $37.51 $26,763 - $31,283	834 Added 1.94%	43,799 $1.45 Million
Q2 2023 Jul 19, 2023	BUY	$36.12 - $41.79 $96,548 - $111,704	2,673 Added 6.63%	42,965 $1.58 Million
Q1 2023 Apr 27, 2023	BUY	$39.39 - $51.28 $4,490 - $5,845	114 Added 0.28%	40,292 $1.64 Million
Q4 2022 Jan 23, 2023	BUY	$41.75 - $54.5 $549,597 - $717,438	13,164 Added 48.73%	40,178 $0
Q3 2022 Oct 28, 2022	BUY	$43.76 - $53.42 $60,476 - $73,826	1,382 Added 5.39%	27,014 $1.18 Million
Q2 2022 Jul 25, 2022	SELL	$46.53 - $55.17 $34,944 - $41,432	-751 Reduced 2.85%	25,632 $1.35 Million
Q1 2022 May 06, 2022	SELL	$45.75 - $56.69 $61,442 - $76,134	-1,343 Reduced 4.84%	26,383 $1.37 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $68,632 - $101,736	1,661 Added 6.37%	27,726 $1.64 Million
Q3 2021 Oct 27, 2021	SELL	$39.25 - $50.42 $15,857 - $20,369	-404 Reduced 1.53%	26,065 $1.12 Million
Q2 2021 Aug 13, 2021	SELL	$35.91 - $40.68 $23,736 - $26,889	-661 Reduced 2.44%	26,469 $1.04 Million
Q1 2021 May 11, 2021	BUY	$33.49 - $37.77 $85,265 - $96,162	2,546 Added 10.36%	27,130 $984,000
Q4 2020 Feb 01, 2021	SELL	$33.47 - $42.56 $916,107 - $1.16 Million	-27,371 Reduced 52.68%	24,584 $906,000
Q3 2020 Oct 29, 2020	BUY	$31.75 - $37.25 $809,942 - $950,247	25,510 Added 96.46%	51,955 $1.91 Million
Q2 2020 Aug 06, 2020	BUY	$30.12 - $36.54 $65,239 - $79,145	2,166 Added 8.92%	26,445 $864,000
Q1 2020 May 05, 2020	SELL	$27.03 - $38.62 $40,436 - $57,775	-1,496 Reduced 5.8%	24,279 $793,000
Q4 2019 Jan 27, 2020	SELL	$32.92 - $37.36 $3,127 - $3,549	-95 Reduced 0.37%	25,775 $1.01 Million
Q3 2019 Nov 04, 2019	BUY	$32.49 - $42.13 $42,756 - $55,443	1,316 Added 5.36%	25,870 $930,000
Q2 2019 Aug 06, 2019	SELL	$36.98 - $41.52 $22,557 - $25,327	-610 Reduced 2.42%	24,554 $1.06 Million
Q1 2019 May 03, 2019	SELL	$37.5 - $41.2 $136,987 - $150,503	-3,653 Reduced 12.68%	25,164 $1.07 Million
Q4 2018 Feb 04, 2019	SELL	$38.47 - $43.86 $19,311 - $22,017	-502 Reduced 1.71%	28,817 $1.26 Million
Q3 2018 Oct 26, 2018	SELL	$34.47 - $41.81 $68,285 - $82,825	-1,981 Reduced 6.33%	29,319 $1.3 Million
Q2 2018 Aug 07, 2018	SELL	$32.98 - $35.16 $137,856 - $146,968	-4,180 Reduced 11.78%	31,300 $1.14 Million
Q1 2018 May 04, 2018	BUY	$31.91 - $37.02 $930,942 - $1.08 Million	29,174 Added 462.64%	35,480 $1.26 Million
Q4 2017 Jan 31, 2018	SELL	$33.26 - $35.29 $934,838 - $991,896	-28,107 Reduced 81.68%	6,306 $228,000
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $1.07 Million - $1.18 Million	34,413	34,413 $1.23 Million

Others Institutions Holding PFE

# of Institutions

3,329

Shares Held

3.68B

Call Options Held

101M

Put Options Held

131M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $143B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspiriant, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspiriant, LLC with notifications on news.

Account